Literature DB >> 8457885

Selective vulnerability of alpha motor neurons in ALS: relation to autoantibodies toward acetylcholinesterase (AChE) in ALS patients.

S Conradi1, L O Ronnevi.   

Abstract

The degenerative process in amyotrophic lateral sclerosis (ALS) concerns primarily alpha motor neurons in the spinal cord and brain stem, and neurons forming descending pathways to the cord, especially in the pyramidal tract. Some degeneration of large peripheral sensory nerve fibers often occurs too, but preganglionic autonomic neurons and gamma motor neurons are most often spared in the disease. The vulnerability of alpha motor neurons compared to other types of neurons in ALS is discussed in relation to retrograde axoplasmic transport from peripheral blood of foreign noxious macromolecules, interneuronal transport of such molecules, and neuronal surface structure properties relevant to uptake for retrograde axoplasmic transport. Certain differences in these aspects between alpha motor neurons and other neuronal types exist. Some differences concern the neuronal turnover of acetylcholinesterase (AChE), which could be of special interest in view of the recent demonstration of regular occurrence of autoantibodies towards this enzyme in ALS patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8457885     DOI: 10.1016/0361-9230(93)90267-f

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  8 in total

1.  Transient mitochondrial permeability transition mediates excitotoxicity in glutamate-sensitive NSC34D motor neuron-like cells.

Authors:  Xiaoyun Liu; Shangcheng Xu; Pei Wang; Wang Wang
Journal:  Exp Neurol       Date:  2015-05-27       Impact factor: 5.330

2.  Gamma motor neurons survive and exacerbate alpha motor neuron degeneration in ALS.

Authors:  Melanie Lalancette-Hebert; Aarti Sharma; Alexander K Lyashchenko; Neil A Shneider
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-07       Impact factor: 11.205

3.  Increased NF-L levels in the TDP-43G298S ALS mouse model resemble NF-L levels in ALS patients.

Authors:  Eva Buck; Patrick Oeckl; Veselin Grozdanov; Verena Bopp; Julia K Kühlwein; Wolfgang P Ruf; Diana Wiesner; Francesco Roselli; Jochen H Weishaupt; Albert C Ludolph; Markus Otto; Karin M Danzer
Journal:  Acta Neuropathol       Date:  2022-05-18       Impact factor: 15.887

Review 4.  Neuroimmunotoxicology: humoral assessment of neurotoxicity and autoimmune mechanisms.

Authors:  H A El-Fawal; S J Waterman; A De Feo; M Y Shamy
Journal:  Environ Health Perspect       Date:  1999-10       Impact factor: 9.031

5.  Molecular changes associated with spinal cord aging.

Authors:  Katarzyna M Piekarz; Shylesh Bhaskaran; Kavithalakshmi Sataranatarajan; Kaitlyn Street; Pavithra Premkumar; Debra Saunders; Michelle Zalles; Rafal Gulej; Shadi Khademi; Jaime Laurin; Rick Peelor; Benjamin F Miller; Rheal Towner; Holly Van Remmen
Journal:  Geroscience       Date:  2020-03-06       Impact factor: 7.581

6.  Mitigation of ALS Pathology by Neuron-Specific Inhibition of Nuclear Factor Kappa B Signaling.

Authors:  Kallol Dutta; Sai Sampath Thammisetty; Hejer Boutej; Christine Bareil; Jean-Pierre Julien
Journal:  J Neurosci       Date:  2020-05-26       Impact factor: 6.167

7.  Potent spinal parenchymal AAV9-mediated gene delivery by subpial injection in adult rats and pigs.

Authors:  Atsushi Miyanohara; Kota Kamizato; Stefan Juhas; Jana Juhasova; Michael Navarro; Silvia Marsala; Nada Lukacova; Marian Hruska-Plochan; Erik Curtis; Brandon Gabel; Joseph Ciacci; Eric T Ahrens; Brian K Kaspar; Don Cleveland; Martin Marsala
Journal:  Mol Ther Methods Clin Dev       Date:  2016-07-13       Impact factor: 6.698

Review 8.  Neurodegenerative Diseases - Is Metabolic Deficiency the Root Cause?

Authors:  Vignayanandam Ravindernath Muddapu; S Akila Parvathy Dharshini; V Srinivasa Chakravarthy; M Michael Gromiha
Journal:  Front Neurosci       Date:  2020-03-31       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.